A pharmacokinetic and safety study to evaluate drug-drug interactions of pravastatin and rosuvastatin coadministered with Direct Acting Antiviral combination of ABT-450/r, ombitasvir, dasabuvir (3D) and ABT-450/r+ombitasvir (2D)

Trial Profile

A pharmacokinetic and safety study to evaluate drug-drug interactions of pravastatin and rosuvastatin coadministered with Direct Acting Antiviral combination of ABT-450/r, ombitasvir, dasabuvir (3D) and ABT-450/r+ombitasvir (2D)

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Sep 2015

At a glance

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top